Clinical Chemistry Podcast cover art

All Episodes

Clinical Chemistry Podcast — 1000 episodes

#
Title
1

Simultaneous Prenatal cfDNA Screening of Aneuploidy, Recessive Single-Gene Conditions, and Fetomaternal Blood Compatibility

2

Audio Summary August 2026

3

From Pooled Cohorts to PREVENT: A Perspective for Clinical Laboratorians

4

Disseminated Coccidioidomycosis in Immunocompetent Hosts: Opportunities for Increased Recognition and Timely Diagnosis

5

Audio Summary July 2026

6

DPYD Sequencing Identifies More Clinically Relevant Variants as Compared to Targeted Genotyping

7

Universal Presence of Gene/Variant Nomenclature Errors in Journal Manuscript Submissions

8

Frameworks of Health Outcomes for Performance Specifications in Laboratory Medicine

9

Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring

10

Audio Summary June 2026

11

Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?

12

Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant Tuberculosis

13

Audio Summary May 2026

14

Quantum Machine Learning and Data Re-Uploading: Evaluation on Benchmark and Laboratory Medicine Data Sets

15

Scientific Fraud at Scale: Challenges for Trust in Published Data

16

Pre-Exposure Prophylaxis (PrEP)-Associated HIV Monitoring and Self-Testing

17

Endogenous Lithium Levels and Alzheimer Disease

18

Audio Summary April 2026

19

PREEMPT'ing Overreliance on Peripheral Blood-Based ColoRectal Cancer Screening

20

A Turning Point for Lipoprotein(a) Treatment: Are Clinical Laboratories Ready?

21

Audio Summary March 2026

22

Global IVD: Barriers, Trends, and Future

23

Uterus Transplantation—Current Evaluation, Monitoring, and Emerging Diagnostics

24

Audio Summary February 2026

25

Unmet Clinical Needs and Remaining Challenges of Pregnancy Reference Intervals

26

From Diagnosis to Delivery: A Look at the Continuing Gap in Maternal Testing

27

Audio Summary January 2026

28

Per se driving under the influence of cannabis statutes and blood delta-9-tetrahydrocannabinol concentrations following short-term cannabis abstinence

29

Regulatory Fragmentation in Europe and Its Risks for Patient Access and Safety: Subcontracting Work Flow Steps of In-House Diagnostic Procedures

30

Transdermal GFR Signals a New Horizon in Renal Diagnostics

31

Modern Low-Density Lipoprotein Cholesterol Formulas Outperform Direct Methods in Patients with Hypertriglyceridemia and Low Levels of Low-Density Lipoprotein Cholesterol

32

Audio Summary December 2025

33

Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use

34

Embracing Generative Artificial Intelligence as a Support Tool for Clinical Decision-Making

35

Diagnostic Value of Digital Estimates of Trophoblastic Mosaicism in Genome-Wide Cell-Free Fetal DNA Screening

36

Risk vs Prevalence: Weighing Routine DPYD Variant Testing Prior to Fluoropyrimidine-Based Chemotherapy

37

Audio Summary November 2025

38

Optimizing Estimation: Perspective on Drug Dosing Using New CKD-EPI Equations

39

Audio Summary October 2025

40

Utilizing the Stability of Individual Homeostatic Setpoints over Time - A Step Forward on the Path to Personalized Laboratory Medicine

41

Advances in Syphilis Diagnostics to Address the 21st-Century Epidemic

42

Machine Learning for Detecting Iron Deficiency through Comprehensive Blood Analysis

43

Toward Improved Prostate Cancer Screening: Insights from the Göteborg-2 Trial

44

Audio Summary September 2025

45

Proteomic Aging Clock Predicts Mortality and Risk of Common Age-Related Diseases

46

Influence of Macrotroponin on the 99th Percentile Threshold in 2 High-Sensitivity Cardiac Troponin Assays

47

Pulse Oximeter Performance across Populations with Diverse Skin Tones

48

Polygenic Effects on Hb A1c May Mask Hyperglycemia and Increase Retinopathy Risk

49

Audio Summary August 2025

50

Reducing the Noise in Plasma Metagenomics to Further Define Clinical Utility

51

Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma

52

Audio Summary July 2025

53

Robotic Process Automation in Laboratory Medicine

54

HOPEing That a PEACEful Resolution for the Clinical Utility of High-Sensitivity Cardiac Troponin in the Ambulatory Setting Will Improve Laboratory Testing

55

Audio Summary June 2025

56

The Slow Progress in Developing Better Long-Term Cardiovascular Risk Assessment in Women Continues

57

Pediatric vaccine-induced antibody thresholds: Rethinking pre-immunosuppression serologic testing and revaccination implications

58

Reevaluating the threshold for low total testosterone

59

Help Us to Help You: Recommendations for Continued Enforcement Discretion for Common Infectious Disease Test Modifications under the FDA Final Rule

60

Audio Summary May 2025

61

New Clinical Practice Guidelines for Vitamin D Supplementation and Testing

62

Normal Thyroid-Stimulating Hormone and Elevated Free Thyroxine in a Patient Presenting with Self-Reported Heart Palpitations

63

Cardiac Biomarkers and Malnutrition Incidence in Community-Dwelling Older Adults without Cardiovascular Disease: The Seniors-ENRICA-2 Cohort

64

Pharmacogenetic Analysis of CYP2C19 for Clopidogrel: Ready for Prime Time

65

Audio Summary April 2025

66

A Multianalyte Machine Learning Model to Detect Wrong Blood in Complete Blood Count Tube Errors in a Pediatric Setting

67

An AI Model (LORIS) to Predict Immune Checkpoint Blockade Response in Cancer: A Clinical Data Science Perspective

68

Audio Summary March 2025

69

New American Society of Hematology Thrombophilia Guidelines Could Provoke Surge in Laboratory Testing

70

Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine

71

Rethinking Albuminuria in Low-Risk Patients and a Call for Urine Albumin Standardization

72

Audio Summary February 2025

73

From the Perspective of the Child: Ethical Considerations for the Implementation of Genomic Sequencing into Neonatal and Pediatric Care

74

Overcoming Barriers to Genomic Medicine Implementation

75

Clonality Determination by Detecting Unmodified Monoclonal Serum Free Light Chains Using On-Probe Extraction Coupled with Liquid Chromatography-High-Resolution Mass Spectrometry

76

Audio Summary January 2025

77

Untargeted Metabolomics for Inborn Errors of Metabolism: Development and Evaluation of a Sustainable Reference Material for Correcting Inter-Batch Variability

78

Novel In-Line Hemolysis Detection on a Blood Gas Analyzer and Impact on Whole Blood Potassium Results

79

Forever Chemicals, Endless Testing? Expert Advice to Be Prepared for Per- and Polyfluoroalkyl Substances

80

Audio Summary December 2024

81

Alzheimer disease blood-based biomarkers: Translation from research into clinical use

82

Deconvolution of human urine across the transcriptome and metabolome

83

Niacin and Risk of Cardiovascular Events: Deciphering the Paradox

84

Audio Summary November 2024

85

Approval of the First CRISPR-Cas9 Gene Editing Therapy for Sickle Cell Disease

86

Personalized Reproductive Hormone Monitoring in Sweat

87

Reference Intervals Revisited: A Novel Model for Population-Based Reference Intervals, Using a Small Sample Size and Biological Variation Data

88

Beyond the Screen: Navigating Remote Work within Medicine

89

Audio Summary October 2024

90

ChatGPT vs Medical Professional: Analyzing Responses to Laboratory Medicine Questions on Social Media

91

Congenital Syphilis: An Emerging, Preventable Public Health Crisis

92

The Era of Early Detection and Treatment of Brain Amyloid Deposition in Asymptomatic Individuals?

93

Audio Summary September 2024

94

Clinical Laboratories Confront a New Wave of Drug Overdose Deaths

95

Audio Summary August 2024

96

Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?

97

Breaking Boundaries: Exploring Performance Enhancement and Anti-Doping Testing in Sports

98

Use of Maternal Race and Weight Provides Equitable Performance in Serum Screening for Open Neural Tube Defects

99

Audio Summary July 2024

100

Biological Insights from Cell-Free DNA Methylome Analysis in Preeclampsia

101

Microbiome-Based Diagnostics for Disease: Where Are We Now and Where Are We Headed?

102

Biomarkers vs Machines: The Race to Predict Acute Kidney Injury

103

Audio Summary June 2024

104

Evaluation of Nanopore Sequencing on Polar Bodies for Routine Pre-Implantation Genetic Testing for Aneuploidy

105

Challenges Associated with the Effective Implementation of New Laboratory Tests—The International Experience

106

Time to Reevaluate the 95% Inclusion Criteria for Defining Reference Intervals?

107

Audio Summary May 2024

108

Large Language Models for Scientific Publishing: Please, Do Not Make Them a Foe

109

Eye Catching Advancement for Creutzfeldt–Jakob Disease Diagnostics

110

More Than a Decade of Rapid Genomic Sequencing: Where Are We Now?

111

Audio Summary April 2024

112

Lower Limits for Reporting High-Sensitivity Cardiac Troponin Assays and Impact of Analytical Performance on Patient Misclassification

113

The Next Clinical Decision Frontier: How to Efficiently and Safely Combine Machine Learning and Human Expertise

114

Clinical Decision Support in Laboratory Medicine

115

Audio Summary March 2024

116

New Sepsis Diagnostics and Their Impacts on Clinical Decision-Making and Treatment Protocols

117

Transport of Full-Length Proteins through a Nanopore: One Step Closer to Single-Molecule Proteomics

118

Automating the Detection of IV Fluid Contamination Using Unsupervised Machine Learning

119

Screening in Multiple Myeloma and Its Precursors: Are We There Yet?

120

Eight Misconceptions about Prostate-Specific Antigen

121

Cancer Screening, Incidental Detection, and Overdiagnosis

122

Audio Summary February 2024

123

Reevaluating the Role of High-Density Lipoprotein Cholesterol: New Perspectives on Cardiovascular Disease and Alzheimer Disease

124

Data Analytics in Clinical Laboratories: Advancing Diagnostic Medicine in the Digital Age

125

Audio Summary January 2024

126

Sensitive Blood-Based Detection of HIV-1 and Mycobacterium tuberculosis Peptides for Disease Diagnosis by Immuno-Affinity Liquid Chromatography–Tandem Mass Spectrometry: A Method Development and Proof-of-Concept Study

127

Audio Summary December 2023

128

Early and Accurate Diagnosis of Parkinson Disease May Be Rooted in Seed Amplification Assays

129

AI Chatbots in Clinical Laboratory Medicine: Foundations and Trends

130

Generalizability of a Machine Learning Model for Improving Utilization of Parathyroid Hormone-Related Peptide Testing across Multiple Clinical Centers

131

Audio Summary November 2023

132

Confirmation of Insertion, Deletion, and Deletion-Insertion Variants Detected by Next-Generation Sequencing

133

Generative Artificial Intelligence: More of the Same or Off the Control Chart?

134

Short Timeframe Prediction of Kidney Failure among Patients with Advanced Chronic Kidney Disease

135

Audio Summary October 2023

136

Reference Interval Harmonization: Harnessing the Power of Big Data Analytics to Derive Common Reference Intervals across Populations and Testing Platforms

137

A Machine Learning Model for the Routine Detection of "Wrong Blood in Complete Blood Count Tube" Errors

138

In-Hospital Manufacturing of Cellular Therapies Using Automated Systems

139

Audio Summary September 2023

140

Feasibility of Targeted Next-Generation DNA Sequencing for Expanding Population Newborn Screening

141

Abatacept as a Mimic of Gamma Heavy Chain Disease

142

Assessing the Accuracy and Clinical Utility of ChatGPT in Laboratory Medicine

143

Audio Summary August 2023

144

Machine Learning in Laboratory Medicine: Recommendations of the IFCC Working Group

145

Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests

146

Tissue Mass Spectrometry: How Solid Is Our Future?

147

Audio Summary July 2023

148

Polygenic Risk Scores: Genomes to Risk Prediction

149

Rapid Rule-Out of Myocardial Infarction Using a Single High-Sensitivity Cardiac Troponin I Measurement Strategy at Presentation to the Emergency Department: The SAFETY Study

150

Using Biomarkers for Traumatic Brain Injury: Are There Lessons That Can Be Learned from Implementing Cardiac Troponin?

151

Audio Summary June 2023

152

The Present and Future of Lipid Testing in Cardiovascular Risk Assessment

153

Multiplexing Homocysteine into First-Tier Newborn Screening Mass Spectrometry Assays Using Selective Thiol Derivatization

154

Lab Medicine in Space

155

Audio Summary May 2023

156

FDA Regulation of Laboratory Clinical Decision Support Software: Is It a Medical Device?

157

The Genotype—Phenotype Conundrum for Antimicrobial Susceptibility Testing

158

Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?

159

Audio Summary April 2023

160

Clinical Perspective on Use of Long-Read Sequencing in Prenatal Diagnosis of Thalassemia

161

Effects of Supplemented Mediterranean Diets on Plasma-Phospholipid Fatty Acid Profiles and Risk of Cardiovascular Disease after 1 Year of Intervention in the PREDIMED Trial

162

A Spotlight on Disruptors and Innovators

163

Audio Summary March 2023

164

Fragment Ends of Circulating Microbial DNA as Signatures for Pathogen Detection in Sepsis

165

Laboratory Preparedness for the Current Monkeypox Outbreak

166

Within-Person and Between-Sensor Variability in Continuous Glucose Monitoring Metrics

167

A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making

168

Audio Summary February 2023

169

Neutral-Coating Capillary Electrophoresis Coupled with High-Resolution Mass Spectrometry for Top-Down Identification of Hemoglobin Variants

170

One Bad Apple Can Spoil the Bunch: The Impact of Contamination in the Clinical Laboratory

171

Can Rapid Nanopore Sequencing Bring Genomic Testing to the Bedside?

172

What is the Importance of Analyzing Tumor Tissues and Blood Cells in the Study of Circulating Tumor-Derived DNA?

173

Audio Summary January 2023

174

Rising to the Challenge: Shortages in Laboratory Medicine

175

Ceramide Risk Scores Can Bring Lipidomics to Clinical Medicine

176

Audio Summary December 2022

177

Identifying Clinically Relevant Bacteria Directly from Culture and Clinical Samples with a Handheld Mass Spectrometry Probe

178

Macrotroponin—Analytical Anomaly or Clinical Confounder

179

The PROVE-HF Study: Additional Proof for the Inclusion of the Manufacturer's Name When Reporting B-Type Natriuretic Peptide Results

180

Clinical Laboratory Informatics and Analytics: Challenges and Opportunities

181

Audio Summary November 2022

182

Cardiac Troponin as a Marker of Heart Failure Risk in Diabetes

183

Estimated Atherosclerotic Cardiovascular Disease Risk Score: An Automated Decision Aid for Statin Therapy

184

Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders

185

Audio Summary October 2022

186

Differences between Educational and Regulatory External Quality Assurance/Proficiency Testing Schemes

187

Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets

188

Rh Blood Group D Antigen Genotyping Using a Portable Nanopore-based Sequencing Device: Proof of Principle

189

Direct-to-Consumer Testing for Routine Purposes

190

Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern

191

Audio Summary September 2022

192

Reproducibility: Has Cancer Biology Failed beyond Repair?

193

Public Misinformation and Science Communication in Times of Public Health Crises

194

Women in Laboratory Medicine: A Q&A on Diversity and Inclusion

195

Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus

196

Critical Roles of Clinical Laboratorians in Translational Research and Applied Sciences—Experts' Insights and Experiences

197

Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum Samples

198

The Need to Develop Clinical Guidance for the Use of High-Sensitivity Cardiac Troponin in Pediatric and Neonatal Patients

199

Audio Summary August 2022

200

Audio Summary July 2022

201

Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test

202

Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia

203

A Novel Approach to Improve Accuracy of CYP2D6 Enzyme Activity and Drug Response Predictions

204

Audio Summary June 2022

205

Toward Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis

206

How Not to Introduce Laboratory Tests to Clinical Practice: Preimplantation Genetic Testing for Aneuploidy

207

New Equations for Estimating Glomerular Filtration Rate

208

A Paradigm Shift: Engagement of Clinical Chemistry and Laboratory Medicine Trainees by Innovative Teaching Methods

209

Glycated Albumin: Added Value or Redundancy in Diabetes Care?

210

Interpreting EQA—Understanding Why Commutability of Materials Matters

211

How Can We Ensure Reproducibility and Clinical Translation of Machine Learning Applications in Laboratory Medicine?

212

Audio Summary May 2022

213

Pregnancy in the Time of COVID-19: What Are the Challenges for Maternity Care?

214

Audio Summary April 2022

215

Alternative Sample Matrices Supporting Remote Sample Collection during the Pandemic and Beyond

216

Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory

217

Audio Summary March 2022

218

Chest Pain Assessment: What Is Our Endgame?

219

Deadly Pathogens, Transformative Technologies, and Protracted Pandemics: Challenges and Opportunities in Laboratory Medicine

220

At-Home Testing for Infectious Diseases: The Laboratory Where You Live

221

Audio Summary February 2022

222

A Push for Real Normal: Mass Screening for COVID-19

223

Audio Summary January 2022

224

Challenges in Translating Clinical Metabolomics Data Sets from the Bench to the Bedside

225

Digital Microfluidic Hemagglutination Assays for Blood Typing, Donor Compatibility Testing, and Hematocrit Analysis

226

Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study

227

Molecular Approaches to Transplant Monitoring; Is the Horizon Here?

228

Audio Summary December 2021

229

Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring

230

Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer

231

The European Biological Variation Study (EuBIVAS): Biological Variation Data for Coagulation Markers Estimated by a Bayesian Model

232

Perspectives on Identifying and Treating Familial Hypercholesterolemia in Childhood

233

Audio Summary November 2021

234

Can High-Sensitivity Troponins Help to Level the Playing Field in Cardiovascular Disease Prevention between Women and Men?

235

TOP-Plus is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability

236

Audio Summary October 2021

237

High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19

238

Cardiac Biomarkers in Pediatrics: An Undervalued Resource

239

Audio Summary September 2021

240

AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories

241

How Well Do Laboratories Adhere to Recommended Guidelines for Cardiac Biomarkers Management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) Study of the European Federation of Laboratory Medicine Task Group on Cardiac Markers

242

Big Data Strikes Again: Future Utilization of the UK Biobank as a Resource for Clinical Laboratories

243

Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results

244

Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap Between Clinical and Laboratory Practice

245

Audio Summary August 2021

246

Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands

247

Laboratory Action Plan for Emerging SARS-CoV-2 Variants

248

Audio Summary July 2021

249

Centralized vs Decentralized Molecular Infectious Disease Testing

250

Is it Time to move on? Reexamining Race in Glomerular Filtration Rate Equations

251

Limitations of Accelerated Stability Model Based on the Arrhenius Equation for Shelf Life Estimation of In Vitro Diagnostic Products

252

Interoperability: COVID-19 as an Impetus for Change.

253

Audio Summary June 2021

254

Audio Summary May 2021

255

Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)

256

Clinical Protein Analysis by Mass Spectrometry: A New Higher Order

257

Audio Summary April 2021

258

Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration

259

Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation

260

The Dynamic and Multifaceted Nature of Cardiovascular Disease and Using Genetic Testing to Inform Clinical Care: An International Perspective

261

Audio Summary March 2021

262

The Vitamin D Metabolite Ratio is Independent of Vitamin D Binding Protein Concentration

263

Audio Summary February 2021

264

Nonfasting Lipid Profile for all Patients?

265

B-Type Natriuretic Peptide Is Associated with Favorable Left Ventricular Function in General Population

266

Audio Summary January 2021

267

Deus ex machina? Predicting SARS-CoV-2 Infection from Lab Tests Using Machine Learning.

268

SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission

269

Cautionary Note on Contamination of Reagents Used for Molecular Detection of SARS-CoV-2

270

Genomic Prediction of Antimicrobial Resistance: Ready or Not, Here It Comes!

271

The Faces of Women in AACC - A Historical Reflection on AACC Leadership and Awards

272

Audio Summary December 2020

273

Cell-free DNA fragmentomics: the new "omics" on the block

274

Audio Summary November 2020

275

Examining Laboratory Medicine's Role in Eliminating Health Disparities

276

Proportion of Donor Specific Cell-Free DNA in Blood as a Marker of Transplant Rejection: Not an Absolute

277

Patient-Based Real Time QC

278

Evaluation of the Risk of Laboratory Microbial Contamination During Routine Testing in Automated Clinical Chemistry and Microbiology Laboratories

279

Audio Summary October 2020

280

In-Depth Analysis of Molecular Heterogeneity of Circulating N-Terminal pro-BNP: Does Detailed Characterization of Analyte Structure Really Matter for its Diagnostic Use?

281

Throughput Considerations for a Sample-Multiplexed LC-MS/MS Assay: Is the Ability to Double the Injection Throughput Always a Time Saver?

282

Recognition of the Pre-hospital Preanalytical Phase: Collaborative Efforts between Laboratory Medicine and Emergency Medicine to Ensure Quality Testing

283

Clinical Performance of Two SARS-CoV-2 Serologic Assays

284

Audio Summary September 2020

285

Machine Learning for the Biochemical Genetics Laboratory

286

Audio Summary August 2020

287

IFCC Working Group Recommendations for Correction of Bias Caused by Noncommutability of a Certified Reference Material Used in the Calibration Hierarchy of an End-User Measurement Procedure

288

Fecal Microbiota Transplantations: Where Are We, Where Are We Going, and What Is the Role of the Clinical Laboratory?

289

Modification of In Vitro Diagnostic Devices: Leveling the Playing Field

290

Audio Summary July 2020

291

July 2020 Summary Peddu

292

July 2020 Summary Caswell

293

July 2020 Summary Pitella-Silva

294

July 2020 Summary Lau

295

July 2020 Summary Jensen

296

July 2020 Summary McGrath

297

June 2020 Summary Benoist

298

June 2020 Summary Min

299

June 2020 Summary Crawford

300

June 2020 Summary Tafess

301

June 2020 Summary Trouillet-Assant

302

June 2020 Summary Pan

303

Audio Summary June 2020

304

SARS-CoV-2 Serology: Much Hype, Little Data

305

Development, Validation, and Regulatory Considerations for a Liquid Biopsy Test

306

Audio Summary May 2020

307

May 2020 Summary Clouet-Foraison

308

May 2020 Summary Liu

309

May 2020 Summary Guo

310

May 2020 Summary Heider

311

May 2020 Summary Hicks

312

May 2020 Summary Colak

313

Calibrating from Within: Multipoint Internal Calibration of a Quantitative Mass Spectrometric Assay of Serum Methotrexate

314

Audio Summary April 2020

315

April 2020 Summary Silveira

316

April 2020 Summary Lam

317

April 2020 Summary Korecka

318

April 2020 Summary Moncrieffe

319

April 2020 Summary Lyngbakken

320

April 2020 Summary Jongejan

321

April 2020 Summary Chu

322

Mass Spectrometry for Identification, Monitoring, and Minimal Residual Disease Detection of M-Proteins

323

Clinical Relevance of the 99th Percentile Upper Reference Limit for High-Sensitivity Cardiac Troponin Assays

324

Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak [Chinese Translation]

325

Sex-Specific 99th Percentile Upper Reference Limits for High Sensitivity Cardiac Troponin Assays Derived Using a Universal Sample Bank

326

Development and Clinical Validation of a Sensitive Lateral Flow Assay for Rapid Urine Fentanyl Screening in the Emergency Department

327

Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak

328

Audio Summary March 2020

329

March 2020 Summary Guo

330

March 2020 Summary Hoffman

331

March 2020 Summary Blesa

332

March 2020 Summary Sun

333

March 2020 Summary Lam

334

March 2020 Summary Apple

335

Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia [Chinese Translation]

336

Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia

337

February 2020 Summary Pruner

338

February 2020 Summary Jin

339

February 2020 Summary Malka

340

February 2020 Summary Vigneron

341

February 2020 Summary Ge

342

February 2020 Summary Starnberg

343

February 2020 Summary Li

344

February 2020 Summary O'Malley

345

Audio Summary February 2020

346

Circulating Tumor DNA for Modern Cancer Management

347

Microbiome Diagnostics

348

Unconventional Diagnosis Based on Somatic Findings through Germ Line Whole-Exome Sequencing

349

Predictive and Precision Medicine with Genomic Data

350

Molecular Diagnostics: Going from Strength to Strength

351

Audio Summary January 2020

352

January 2020 Summary Coelho-Lima

353

January 2020 Summary Wu

354

January 2020 Summary Profaizer

355

January 2020 Summary Zucha

356

January 2020 Summary Chandler

357

January 2020 Summary Gotway

358

January 2020 Summary Ge

359

January 2020 Summary Song

360

January 2020 Summary Lin

361

January 2020 Summary Joosse

362

January 2020 Summary Lampignano

363

Ethics for Laboratory Medicine

364

Laboratory Measurement's Contribution to the Replication and Application Crisis in Clinical Research

365

Audio Summary December 2019

366

December 2019 Summary Sorensen

367

December 2019 Summary Meisterzheim

368

December 2019 Summary Weber

369

December 2019 Summary Salamin

370

December 2019 Summary Sun

371

December 2019 Summary Yang

372

December 2019 Summary Wussler

373

December 2019 Summary Hughey

374

December 2019 Summary Costenbader

375

Circular RNAs as Urinary Biomarkers

376

ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure

377

An Intact ACTH LC-MS/MS Assay as an Arbiter of Clinically Discordant Immunoassay Results

378

Audio Summary November 2019

379

November 2019 Summary Bansal

380

November 2019 Summary Nestelberger

381

November 2019 Summary Boeddinghaus

382

November 2019 Summary Yang

383

November 2019 Summary O' Leary

384

November 2019 Summary Shi

385

November 2019 Summary van Faassen

386

November 2019 Summary Potter

387

A View on the Interrelationship between Obesity and Natriuretic Peptide Measurements: Can Dysregulation in pro–B-type Natriuretic Peptide Glycosylation Explain Decreased B-type Natriuretic Peptide Concentrations in Obese Heart Failure Patients?

388

Urinary Amino-Terminal Pro–C-Type Natriuretic Peptide: A Novel Marker of Chronic Kidney Disease in Diabetes

389

Role of BNP vs NT-proBNP Testing in the Age of New Drug Therapies: Sacubitril-Valsartan

390

Once-Per-Visit Alerts: A Means to Study Alert Compliance and Reduce Repeat Laboratory Testing

391

Detection of Neprilysin-Derived BNP Fragments in the Circulation: Possible Insights for Targeted Neprilysin Inhibition Therapy for Heart Failure

392

Audio Summary October 2019

393

October 2019 Summary Hoq

394

October 2019 Summary Takahashi

395

October 2019 Summary van Tol

396

October 2019 Summary Kolling

397

October 2019 Summary Sun

398

October 2019 Summary Garrel

399

October 2019 Summary Chan

400

October 2019 Summary Prickett

401

October 2019 Summary Feygina

402

Optimal Use of Biomarkers for Chronic Kidney Disease

403

September 2019 Summary Lynch

404

September 2019 Summary Ma

405

September 2019 Summary Cassinari

406

September 2019 Summary Lampasona

407

September 2019 Summary Lampignano

408

September 2019 Summary Szymanski

409

September 2019 Summary Lewis

410

September 2019 Summary IIkezaki

411

Audio Summary September 2019

412

Patient-Based Real-Time Quality Control: Review and Recommendations

413

The National Glycohemoglobin Standardization Program: Over 20 Years of Improving Hemoglobin A1c Measurement

414

Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling

415

Audio Summary August 2019

416

August 2019 Summary Chen

417

August 2019 Summary Kuusisto

418

August 2019 Summary Carobene2

419

August 2019 Summary Hjort

420

August 2019 Summary Sepiashvili

421

August 2019 Summary Body

422

August 2019 Summary Roraas

423

August 2019 Summary He

424

Audio Summary July 2019

425

July 2019 Summary Cheng

426

July 2019 Summary JLi

427

July 2019 Summary Tan

428

July 2019 Summary Boeddinghaus

429

July 2019 Summary Vylegzhanina

430

03 Summary Lyngbakken

431

July 2019 Summary Whitman

432

July 2019 Summary Grammer

433

Low HDL Cholesterol and High Risk of Autoimmune Disease: Two Population-Based Cohort Studies Including 117341 Individuals

434

Inspiring Minds-: Patrick Bossuyt

435

What the Protecting Access to Medicare Act Means for Clinical Laboratories

436

A Message to Medical School Promotion Committees: Proper Credit for Peer-Reviewed Online Educational Materials

437

Generation of Highly Biomimetic Quality Control Materials for Noninvasive Prenatal Testing Based on Enzymatic Digestion of Matched Mother–Child Cell Lines

438

Audio Summary June 2019

439

June 2019 Summary Li

440

June 2019 Summary Burkve

441

June 2019 Summary Zelniker

442

June 2019 Summary Matin

443

June 2019 Summary Zhang

444

June 2019 Summary Mendelian Randomization Group

445

Increased Clinical Sensitivity and Specificity of Plasma Protein N-Glycan Profiling for Diagnosing Congenital Disorders of Glycosylation by Use of Flow Injection–Electrospray Ionization–Quadrupole Time-of-Flight Mass Spectrometry

446

Privacy in Direct-to-Consumer Genetic Testing

447

Parameters for Validating a Hospital Pneumatic Tube System

448

May 2019 Summary Farnsworth

449

May 2019 Summary Hartley

450

May 2019 Summary Sans

451

May 2019 Summary Yu

452

May 2019 Summary Chen

453

May 2019 Summary Madsen

454

Audio Summary May 2019

455

Can Mendelian Randomization Shift into Reverse Gear?

456

Challenges in the Assessment and Diagnosis of Polycystic Ovary Syndrome

457

A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of Disease

458

Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS

459

Which Methods for Determining Glomerular Filtration Rate Most Strongly Associate with Risk of Progression of Kidney Disease?

460

Audio Summary April 2019

461

April 2019 Summary Jones

462

April 2019 Summary Yin

463

April 2019 Summary Jung

464

April 2019 Summary Franken

465

April 2019 Summary Fredsoe

466

April 2019 Summary Norman

467

Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain

468

Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia

469

March 2019 Summary Anand

470

March 2019 Summary Braga

471

March 2019 Summary Riethdorf

472

March 2019 Summary Rackow

473

March 2019 Summary Boeddinghaus

474

March 2019 Summary Mohammadi-Shemirani

475

March 2019 Summary Toes-Zoutendijk

476

March 2019 Summary Freed

477

Audio Summary March 2019

478

Development and Validation of Apolipoprotein AI-Associated Lipoprotein Proteome Panel for the Prediction of Cholesterol Efflux Capacity and Coronary Artery Disease

479

Using Machine Learning to Aid the Interpretation of Urine Steroid Profiles

480

Audio Summary February 2019

481

February 2019 Summary Wood

482

February 2019 Summary Hansen

483

February 2019 Summary Boot

484

February 2019 Summary Breidthardt

485

February 2019 Summary Salameh

486

February 2019 Summary Jin

487

February 2019 Summary Kong

488

February 2019 Summary Myrick

489

Assessment of Digital PCR as a Primary Reference Measurement Procedure to Support Advances in Precision Medicine

490

Differences in Health Outcomes between Men and Women: Biological, Behavioral, and Societal Factors

491

Male Contraceptive Development: Update on Novel Hormonal and Nonhormonal Methods

492

Redesigning Prostate Cancer Screening Strategies to Reduce Overdiagnosis

493

Updates on Screening, Prevention, Treatment, and Genetic Markers for Preeclampsia

494

CRISPR Methods for Nucleic Acid Detection Herald the Future of Molecular Diagnostics

495

Audio Summary January 2019

496

January 2019 Summary Winston-McPherson

497

January 2019 Summary Marrone

498

January 2019 Summary Srinivasan

499

January 2019 Summary Mikkelsen

500

January 2019 Summary SoRelle

501

January 2019 Summary Jayasena

502

Direct Comparison of Cardiac Troponin T and I using a Uniform and a Sex-specific Approach in the Detection of Functionally Relevant Coronary Artery Disease

503

Influence of Molecular Testing on Influenza Diagnosis

504

Decmeber 2018 Summary Huang

505

December 2018 Summary Kiehl

506

December 2018 Summary Folch

507

December 2018 Summary Liu

508

December 2018 Summary Milosevic

509

December 2018 Summary Hejl

510

December 2018 Summary Smith

511

December 2018 Summary Neumann

512

Audio Summary December 2018

513

Audio Summary November 2018

514

November 2018 Summary Parker

515

November 2018 Summary Eisenhofer

516

November 2018 Summary Sharma

517

November 2018 Summary Mansukhani

518

November 2018 Summary Ibrahim

519

November 2018 Summary Welsh

520

November 2018 Summary Mueller

521

November 2018 Summary Wilkes

522

Current and Emerging Trends in Point-of-Care Technology and Strategies for Clinical Validation and Implementation

523

Commutability Assessment of Candidate Reference Materials for Pancreatic α-Amylase

524

October 2018 Summary Zavridou

525

October 2018 Summary Li

526

October 2018 Summary Joosse

527

October 2018 Summary Lee

528

October 2018 Summary Delatour

529

October 2018 Summary Beck

530

October 2018 Summary Kabe

531

October 2018 Summary Andini

532

Audio Summary October 2018

533

September 2018 Summary Wald

534

September 2018 Summary Aarsand

535

September 2018 Summary Myhre

536

September 2018 Summary Caironi

537

September 2018 Summary Boeddinghaus

538

September 2018 Summary Silva

539

September 2018 Summary Guo

540

September 2018 Summary Darebna

541

Audio Summary September 2018

542

Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification

543

Toward a Global Overview of HbA1c Test Performance

544

Preanalytical Processing and Biobanking Procedures of Biological Samples for Metabolomics Research

545

Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial: A Case–Cohort Study

546

Characterization of Human Salivary Extracellular RNA by Next-generation Sequencing

547

RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients

548

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

549

Audio Summary August 2018

550

August 2018 Summary Gai

551

August 2018 Summary Kim

552

August 2018 Summary Cannaert

553

August 2018 Summary Yu

554

August 2018 Summary Tobias

555

August 2018 Summary Deprez

556

August 2018 Summary EurA1C Group

557

Full-Size Cardiac Troponin I and Its Proteolytic Fragments in Blood of Patients with Acute Myocardial Infarction: Antibody Selection for Assay Development

558

Audio Summary July 2018

559

July 2018 Summary Rasmussen

560

July 2018 Summary Katrukha

561

July 2018 Summary Alimohamed

562

July 2018 Summary Li

563

July 2018 Summary Ludwig

564

July 2018 Summary Hogan

565

July 2018 Summary Keup

566

July 2018 Summary Than

567

Clinical Utility of Transcriptome Sequencing: Toward a Better Diagnosis for Mendelian Disorders

568

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study

569

Clinical Evaluation of a Blood Assay to Diagnose Paucibacillary Tuberculosis via Bacterial Antigens

570

Audio Summary June 2018

571

June 2018 Summary Schirmer

572

June 2018 Summary Waalkes

573

June 2018 Summary Wu

574

June 2018 Summary Willemse

575

June 2018 Summary Cannaert

576

June 2018 Summary Ismail

577

Clinical and Genomic Insights from Metastatic Cancers

578

From DESI to the MasSpec Pen: Ambient Ionization Mass Spectrometry for Tissue Analysis and Intrasurgical Cancer Diagnosis

579

Evaluating Rapid Rule-out of Acute Myocardial Infarction Using a High-Sensitivity Cardiac Troponin I Assay at Presentation

580

Audio Summary May 2018

581

May 2018 Summary Hilderink

582

May 2018 Summary Selvin

583

May 2018 Summary Haselmann

584

May 2018 Summary Greenslade

585

May 2018 Summary X Liu

586

May 2018 Summary Rejali

587

May 2018 Summary C Liu

588

Advanced Whole-Genome Sequencing and Analysis of Fetal Genomes from Amniotic Fluid

589

Comparing Measures of HDL: On the Right Path with the Wrong Map

590

The Biological Variation Data Critical Appraisal Checklist: A Standard for Evaluating Studies on Biological Variation

591

Audio Summary April 2018

592

April 2018 Summary vanderGugten

593

April 2018 Summary Kim

594

April 2018 Summary Mao

595

April 2018 Summary Amr

596

April 2018 Summary Topbas

597

April 2018 Summary Masi

598

April 2018 Summary deRond

599

Non-invasive Detection of Cocaine and Heroin Use Using Single Fingerprints

600

Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe

601

Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome

602

IFCC Working Group Recommendations for Assessing Commutability

603

Evaluation of Thyroid Function during Pregnancy: Have We Taken a Wrong Turn?

604

March 2018 Summary Badertscher

605

Audio Summary March 2018

606

March 2018 Summary Pavo

607

March 2018 Summary Eisenhofer

608

March 2018 Summary Tijms

609

March 2018 Summary Frobel

610

March 2018 Summary Kim

611

March 2018 Summary Greiner

612

March 2018 Summary El Heliebi

613

March 2018 Summary Zhou

614

March 2018 Summary Aarsand

615

March 2018 Summary Matera

616

Audio Summary February 2018

617

February 2018 Summary Walter

618

February 2018 Summary Moen

619

February 2018 Summary Prickett

620

February 2018 Summary Ruel

621

February 2018 Summary Hill

622

February 2018 Summary Camunas-Soler

623

February 2018 Summary Dharajiya

624

February 2018 Summary Decraene

625

February 2018 Summary Aalipour

626

February 2018 Summary Markou

627

February 2018 Summary Westgard

628

February 2018 Summary Farrokhi

629

Dietary Fat: Friend or Foe?

630

Use of Metabolomics in Improving Assessment of Dietary Intake

631

Bad Breaks and Metabolic Effects of Bariatric Surgery

632

New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management

633

High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders

634

January 2018 Summary Ahmad

635

January 2018 Summary Varbo

636

January 2018 Summary Castillo

637

January 2018 Summary Ndumele

638

January 2018 Summary Astley

639

January 2018 Summary Mendelian Group

640

Audio Summary January 2018

641

Clinical Case Study: Unusual Cause of Abdominal Pain and Anemia

642

Using Biomarkers to Guide Heart Failure Therapy

643

Audio Summary December 2017

644

December 2017 Summary Silbernagel

645

December 2017 Summary Jagodzinski

646

December 2017 Summary Tolbus

647

December 2017 Summary McCudden

648

December 2017 Summary Durant

649

December 2017 Summary Taylor

650

December 2017 Summary Hines

651

The Role of Procalcitonin in Diagnosis of Sepsis and Antibiotic Stewardship: Opportunities and Challenges

652

Audio Summary November 2017

653

November 2017 Summary Diao

654

November 2017 Summary Costa

655

November 2017 Summary Noceti

656

November 2017 Summary Ferencik

657

November 2017 Summary Langsted

658

November 2017 Summary Cao

659

November 2017 Summary Pan

660

High-Sensitivity Troponin: Star Player but No Lone Hero

661

Implementing a Reference Measurement System for C-Peptide: Successes and Lessons Learned

662

Audio Summary October 2017

663

October 2017 Summary DeGrande

664

October 2017 Summary Gool

665

October 2017 Summary Pryor

666

October 2017 Summary Lam

667

October 2017 Summary Ladas

668

October 2017 Summary Sandoval

669

October 2017 Summary Bredemeier

670

Overinterpretation of Research Findings: Evidence of "Spin" in Systematic Reviews of Diagnostic Accuracy Studies

671

Patient Privacy and Clinical Laboratory Data

672

When Gender Identity Doesn't Equal Sex Recorded at Birth: The Role of the Laboratory in Providing Effective Healthcare to the Transgender Community

673

Audio Summary September2017

674

September 2017 Summary Carobene

675

September 2017 Summary Cardenas-Gonzalez

676

September 2017 Summary Do

677

September 2017 Summary Ebai

678

September 2017 Summary Kahaly

679

September 2017 Audio Summary Kahraman

680

September 2017 Audio Summary Zhang

681

Facilitating Prospective Registration of Diagnostic Accuracy Studies: A STARD Initiative

682

August 2017 Audio Summary

683

August 2017 Audio Summary Eggers

684

August 2017 Audio Summary Wang

685

August 2017 Audio Summary Sillence

686

August 2017 Audio Summary Bietenbeck

687

August 2017 Audio Summary Christenson

688

August 2017 Audio Summary Liao

689

August 2017 Audio Summary McGrath

690

Harmonization: Its Time Has Come

691

Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non–ST-Segment Elevation Acute Coronary Syndrome

692

July 2017 Audio Summary

693

July 2017 Audio Summary Schrock

694

July 2017 Audio Summary Harada

695

July 2017 Audio Summary Liao

696

July 2017 Audio Summary Ong

697

July 2017 Audio Summary Thienpont

698

July 2017 Audio Summary Duprez

699

July 2017 Audio Summary Wildi

700

July 2017 Audio Summary Chan

701

Thrombin-Mediated Degradation of Human Cardiac Troponin T

702

Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry

703

June 2017 Audio Summary

704

June 2017 Audio Summary Kobylecki

705

June 2017 Audio Summary Carobene

706

June 2017 Audio Summary Lian

707

June 2017 Audio Summary Liu

708

June 2017 Audio Summary Lewis

709

June 2017 Audio Summary Dieplinger

710

June 2017 Audio Summary Katrukha

711

Fifty Shades of Yellow

712

May 2017 Audio Summary

713

Association of Blood Eosinophil and Blood Neutrophil Counts with Asthma Exacerbations in the Copenhagen General Population Study

714

FullIssueSummary April2017

715

Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair

716

Are THC Levels in Oral Fluids and Blood Plasma Comparable after Oral Ingestion of Edibles Containing Cannabis or THC?

717

High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis

718

Bone Turnover Markers in the Diagnosis and Monitoring

719

Clinical Chemistry's Commitment to Education: Stronger than Ever

720

Patient Consent and the Commercialization of Lab Data

721

FullIssueSummary February2017

722

Diurnal Rhythm of Cardiac Troponin: Consequences for the Diagnosis of Acute Myocardial Infarction

723

Universal Haplotype-Based Noninvasive Prenatal Testing for Single Gene Diseases

724

Short-term variability of vitamin D-related biomarkers

725

Early rule-out and rule-in strategies for myocardial infarction

726

Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease

727

Biomarkers for Clinical Decision-Making in the Management of Pulmonary Embolism

728

Immediate Rule-Out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin I

729

Myocardial Infarction Type 2 and Myocardial Injury

730

Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction

731

FullIssueSummary January2017

732

Alcohol consumption and cardiac biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study

733

Is the $1,000 genome as near as we think? A cost analysis of next-generation sequencing

734

Optimization of a Moving Averages Program Using a Simulated Annealing Algorithm

735

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

736

Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry

737

A Study of Hypermethylated Circulating Tumor

738

What Can a Clinical Chemist Learn from Aviation?

739

FullIssueSummary September16

740

Full Audio Summary September16

741

Can't Touch This! Contamination of Laboratory Equipment with Bloodborne Pathogens

742

Discordance with 3 Cardiac Troponin I and T Assays: Implications for the 99th Percentile Cutoff

743

Ready, Set, Type! Proteomics vs Agglutination for Escherichia coli H Antigen Confirmation

744

The Promise-and Pitfalls-of Computerized Provider Alerts for Laboratory Test Ordering

745

Classifying Germline Sequence Variants in the Era of Next-Generation Sequencing

746

A 30-Year-Old Patient Who Refuses to Be Drug Tested

747

Full Audio Summary July16

748

Plasma Branched-Chain Amino Acids and Incident Cardiovascular Disease in the PREDIMED Trial

749

Incorporating Clinical Considerations into Statistical Analyses of Markers: A Quiet Revolution in How We Think About Data

750

Smartphones Can Monitor Medical Center Pneumatic Tube Systems

751

Postmarket Surveillance of Point-of-Care Glucose Meters through Analysis of Electronic Medical Records

752

Pharmacists in the Laboratory Space: Friends or Foes?

753

FullIssueSummary June2016

754

Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter

755

Soluble CRTC3: A Newly Identified Protein Released by Adipose Tissue That Is Associated with Childhood Obesity

756

Effect of Dried Blood Spot Quality on Newborn Screening Analyte Concentrations and Recommendations for Minimum Acceptance Criteria for Sample Analysis

757

FullIssueSummary May2016

758

Nonfasting Sample for the Determination of Routine Lipid Profile: Is It an Idea Whose Time Has Come?

759

Mass Spectrometry–Based Adrenal and Peripheral Venous Steroid

760

Paper-Based Quantification of Male Fertility Potential

761

FullIssueSummary April2016

762

Clostridium difficile—Diagnostic and Clinical Challenges

763

Paper-Based Quantification of Male Fertility Potential

764

FullIssueSummary March2016

765

Impact of Implementing Preanalytical Laboratory Standards on the Diagnosis of Gestational Diabetes Mellitus: A Prospective Observational Study

766

Effect of Vitamin D or Activated Vitamin D on Circulating 1,25- Dihydroxyvitamin D Concentrations

767

Serum Total Testosterone Concentrations in the US Household Population from the NHANES 2011–2012 Study Population

768

FullIssueSummary February2016

769

Measurement by a Novel LC-MS/MS Methodology Reveals Similar Serum Concentrations of Vitamin D–Binding Protein in Blacks and Whites

770

US Food and Drug Administration Perspectives on Clinical Mass Spectrometry

771

Ambient Ionization Mass Spectrometry for Point-of-Care Diagnostics and Other Clinical Measurements

772

Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration

773

High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes

774

Protein-Specific Glycoprofiling for Patient Diagnostics

775

Mass Spectrometry Selectivity, Specifically

776

FullIssueSummary January2016

777

Performance of Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate Equations Depends on Patient Characteristics

778

"Big Data" in Laboratory Medicine

779

Optimizing Early Rule-Out Strategies for Acute Myocardial Infarction: Utility of 1-Hour Copeptin

780

Obese Nondiabetic Pregnancies and High Maternal Glycated Hemoglobin at Delivery as an Indicator of Offspring and Maternal Postpartum Risks:

781

STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies

782

FullIssueSummary November2015

783

Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population

784

Nonfasting Lipid Profiles: The Way of the Future

785

Clopidogrel and CYP2C19: Pharmacogenetic Testing Ready for Clinical Prime Time?

786

Next-Generation Microfluidic Point-of-Care

787

FullIssueSummary October2015

788

Difference in Bias Approach for Commutability Assessment: Application to Frozen Pools of Human Serum Measured by 8 Direct Methods for HDL and LDL Cholesterol.

789

FullIssueSummary September2015

790

Pediatric Lipid Screening Rates in the US Are Low: What Can Labs Do to Help?

791

FullIssueSummary August2015

792

Why Disruptive Innovations Matter in Laboratory Diagnostics

793

Intersection of DNA Privacy and Whole-Genome Sequencing

794

FullIssueSummary July2015

795

24,25-Dihydroxyvitamin D3 and Vitamin D Status of Community-Dwelling Black and White Americans

796

Preanalytical Considerations in the Design of Clinical Trials and Epidemiological Studies

797

To Monitor Dabigatran or Not: A Matter of Patient Safety

798

Validation of New Cancer Biomarkers: A Position Statement from the European Group on Tumor Markers

799

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cutpoints—a joint consensus statement from the European Atherosclerosis Society and European Feder

800

FullIssueSummary June2015

801

Investigation of 2 Models to Set and Evaluate Quality Targets for Hb A1c: Biological Variation and Sigma-Metrics

802

FullIssueSummary May2015

803

Current Evidence and Future Perspectives on the Effective Practice of Patient-Centered Laboratory Medicine

804

Vitamin D: The More We Know, the Less We Know

805

FullIssueSummary April2015

806

Qualitative Point-of-Care Human Chorionic Gonadotropin Testing: Can We Defuse This Ticking Time Bomb?

807

Adaptive learning and medical education

808

Validation of a Proposed Novel Equation for Estimating LDL Cholesterol

809

Is This a Critical, Panic, Alarm, Urgent, or Markedly Abnormal Result?

810

Proposed Regulatory Framework for Direct-to-Consumer Genetic Testing: Diagnostics vs Genetic Screening

811

FullIssueSummary March2015

812

Learning from Our Mistakes: The Future of Validating Complex Diagnostics

813

Association of 1,5-Anhydroglucitol with Diabetes and Microvascular Conditions

814

Moving beyond mean glycemia: 1,5-anhydroglucitol and microvascular complications of diabetes

815

Noninvasive Prenatal Testing for Wilson Disease by Use of Circulating Single-Molecule Amplification and Resequencing Technology (cSMART)

816

The Landscape of MicroRNA, Piwi-Interacting RNA, and Circular RNA in Human Saliva

817

FullIssueSummary February2015

818

Clinical Exome Performance for Reporting Secondary

819

Next Generation Sequencing in Clinical Diagnostics: Experiences of Early

820

Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer

821

Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 Countries

822

Extreme PCR: Efficient and Specific DNA Amplification in 15–60 Seconds

823

Total and Cause-Specific Mortality by Moderately and Markedly Increased Ferritin Concentrations: General Population Study and Metaanalysis

824

FullIssueSummary January2014

825

FullIssueSummary January2015

826

ClinChem 201411 Vaught

827

Integrative Bioinformatics Analysis Reveals New Prognostic Biomarkers of Clear Cell Renal Cell Carcinoma

828

Clinical Genomics: When Whole Genome Sequencing is like a Whole-body CT Scan

829

FullIssueSummary December2014

830

FullIssueSummary December2015

831

Emory: Experience with Ebola Patients

832

T2 Magnetic Resonance: A Diagnostic Platform for Studying Integrated Hemostasis in Whole Blood—Proof of Concept

833

Point/Counterpoint: The Quest for Clean Competition in Sports

834

Microfluidic Genotyping by Rapid Serial PCR and High-Speed Melting Analysis

835

FullIssueSummary November2014

836

Generation of a New Cystatin C–Based Estimating Equation for Glomerular Filtration Rate by Use of 7 Assays Standardized to the International Calibrator

837

Where Are All the New Omics-Based Tests?

838

Early Detection of Fragile X Syndrome: Applications of a Novel Approach for Improved Quantitative Methylation Analysis in Venous Blood and Newborn Blood Spots.

839

From Lost in Translation to Paradise Found: Enabling Protein Biomarker Method Transfer by Mass Spectrometry

840

FullIssueSummary October2014

841

Three of 7 Hemoglobin A1c Point-of-Care Instruments Do Not Meet Generally Accepted Analytical Performance Criteria

842

Influence of the Confounding Factors Age and Sex on MicroRNA Profiles from Peripheral Blood

843

Maternal Plasma RNA Sequencing for Genome-Wide Transcriptomic Profiling and Identification of Pregnancy-Associated Transcripts

844

Podcasts Go Platinum!

845

Measurements for 8 Common Analytes in Native Sera Identify Inadequate Standardization among 6 Routine Laboratory Assays

846

FullIssueSummary September2014

847

Immunoextraction - tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free beta, and beta core fragment in urine

848

To P or not to P: that is the question

849

Weekly and 90-Minute Biological Variations in Cardiac Troponin T and Cardiac Troponin I in Hemodialysis Patients and Healthy Controls

850

FullIssueSummary August2014

851

Biomarkers of Brain Injury in Cerebral Infections

852

Novel Biomarkers for Acute Myocardial Infarction: Is MicroRNA the New Kid on the Block?

853

ClinChem 201406 deLemos Khalili

854

FullIssueSummary July2014

855

Harmonization of Test Results: What Are the Challenges; How Can We Make It Better?

856

The FDA and 23andMe: Violating the First Amendment or Protecting the Rights of Consumers?

857

When a “Disease-Causing Mutation” Is Not a Pathogenic Variant

858

Genetically Low Triglycerides and Mortality: Further Support for “the Earlier the Better”?

859

FullIssueSummary June2014

860

Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A

861

Interlaboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured by Mass Spectrometry

862

Interferon γ–Release Assays for Diagnosis of Latent Tuberculosis in Healthcare Workers in Low-Incidence Settings: Pros and Cons

863

Development of an Immunoassay for the Kidney-Specific Protein myo-

864

Posttransplantation Bone Marrow Assessment by Quantifying Hematopoietic Cell–Derived mRNAs in Plasma Exosomes/Microvesicles

865

Sandwich Assay for Tacrolimus Using 2 Antitacrolimus Antibodies

866

Novel Uses for Platelet Function Testing in the Clinical Laboratory: Where Are We Now?

867

Publication and Reporting of Test Accuracy Studies Registered in ClinicalTrials.gov

868

Screening Method to Evaluate Point-of-Care Human Chorionic Gonadotropin (hCG) Devices for Susceptibility to the Hook Effect by hCG β Core Fragment: Evaluation of 11 Devices

869

Influence of PCR Reagents on DNA Polymerase Extension Rates Measured on Real-Time PCR Instruments

870

FullIssueSummary April2014

871

Islet autoantibodies and type 1 diabetes: does the evidence support screening?

872

Digital PCR as a Novel Technology and Its Potential Implications for Molecular Diagnostics

873

Diagnosis of Gestational Diabetes Mellitus: it is time for international consensus

874

Invention and Validation of an Automated Camera System That Uses Optical Character Recognition to Identify Patient Name Mislabeled Specimens

875

FullIssueSummary March2014

876

FullIssueSummary May2014

877

Diagnosis of Gestational Diabetes Mellitus: It Is Time for International Consensus.

878

Biomarkers for Acute Kidney Injury: Where Are We Today? Where Should We Go?

879

Genomic Test Validation for Incidental Findings

880

As if Biomarker Discovery wasn’t Hard Enough

881

FullIssueSummary February2014

882

High-Sensitivity Cardiac Troponin Assays: Isn't It Time for Equality?

883

Tumor Microenvironment–Released Peptides: Could They Form the Basis for an Early-Diagnosis Breast Cancer Test?

884

What’s Different about Women’s Health?

885

The Ethical Implications of Preimplantation Genetic Diagnosis

886

Gestational Diabetes Mellitus

887

Diagnosing Diabetes Mellitus: Performance of Hemoglobin A1c Point-of-Care Instruments in General Practice Offices

888

FullIssueSummary December2013

889

Digital Droplet PCR for Rapid Quantification of Donor DNA in the Circulation of Transplant Recipients as a Potential Universal Biomarker of Graft Injury

890

Multiplex Picodroplet Digital PCR to Detect KRAS

891

MicroRNA Signature Helps Distinguish Early from Late Biochemical Failure in Prostate Cancer

892

FullIssueSummary November2013

893

Bioinformatics: What the Clinical Laboratorian Needs to Know and Prepare For

894

Use of MALDI-TOF for diagnosis of microbial infections

895

ClinChem 201310 Rifai

896

False Biomarker Discovery Due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125

897

FullIssueSummary October2013

898

Scanning for cancer genomic changes in plasma: towards an era of personalized blood-based tumor markers

899

Automation in the Clinical Microbiology Laboratory

900

Automation in the Clinical Microbiology Laboratory

901

Point-of-Care and Over-the-Counter Qualitative Human Chorionic Gonadotropin (hCG) Devices Remain Susceptible to False-Negative Results Caused by Excess hCG β Core Fragment

902

Twenty-Eight Grams of Prevention Is Worth a Half Kilogram of Cure

903

FullIssueSummary September2013

904

A New Era in Prenatal Diagnosis: The Use of Cell-Free Fetal DNA in Maternal Circulation for Detection of Chromosomal Aneuploidies

905

Failure of Current Laboratory Protocols to Detect Lot-to-Lot Reagent Differences: Findings and Possible Solutions

906

ClinChem 201308 Korf

907

FullIssueSummary August2013

908

FDA Oversight of Laboratory-Developed Tests: Is It Necessary, and How Would It Impact Clinical Laboratories?

909

FDA Oversight of Laboratory-Developed Tests: Is It Necessary, and How Would It Impact Clinical Laboratories?

910

FDA Oversight of Laboratory-Developed Tests: Is It Necessary, and How Would It Impact Clinical Laboratories?

911

Noninvasive Prenatal Methylomic Analysis by Genomewide Bisulfite Sequencing of Maternal Plasma DNA

912

Gaps in the Traceability Chain of Human Growth Hormone Measurements

913

Newborn Screening by Sequence and the Road Ahead

914

Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β1–42 and τ Proteins as Alzheimer Disease Biomarkers

915

FullIssueSummary July2013

916

Measurement of Thyroglobulin by Liquid Chromatography–Tandem Mass Spectrometry in Serum and Plasma in the Presence of Antithyroglobulin Autoantibodies

917

Cobalt and Chromium Measurement in Patients with Metal Hip Prostheses

918

Beyond LDL-C in assessing cardiovascular risk: ApoB or LDL-P?

919

FullIssueSummary June2013

920

Are Biomarkers the Answer to the Heart Failure Readmissions Problem?

921

Vitamin D and Cancer: Can We Believe the Evidence from Observational Studies?

922

Circulating MicroRNAs: What Is Their Relevance?

923

Molecular detection of human H7N9 influenza A virus causing outbreaks in China

924

Targeting the Circulating MicroRNA Signature of Obesity

925

FullIssueSummary May2013

926

The Economic Potential of Pharmacogenomics

927

The Human Gut Microbiome and Body Metabolism: Implications for Obesity and Diabetes

928

Q&A on Pheochromocytoma

929

Mobile device for disease diagnosis and data tracking in resource-limited settings

930

MicroRNAs in Idiopathic Childhood Nephrotic Syndrome

931

Predicting the Cost and Pace of Pharmacogenomic Advances: An Evidence-Based Study

932

Communication of Scientific Information: Is It Time to Reassess?

933

FullIssueSummary April2013

934

Male Infertility and Microchips

935

Cannabis Effects on Driving Skills

936

ClinChem 201305 Nordestgaard

937

More Data, Please!

938

MALDI-TOF Mass Spectrometry: Transformative Proteomics for Clinical Microbiology

939

FullIssueSummary March2013

940

Is Early Detection of Cancer with Circulating Biomarkers Feasible?

941

External Quality Assessment of Point-of-Care Methods: Model For Combined Assessment of Method Bias and Single-Participant Performance by the Use of Native Patient Samples and Noncommutable Control Material

942

MicroRNA Analysis: Is It Ready for Prime Time?

943

Commercial Immunoassays in Biomarkers Studies: Researchers Beware!

944

Data Submission and Quality in Microarray-Based MicroRNA Profiling

945

Comparing Multiple Measures of Glycemia: How to Transition from Biomarker to Diagnostic Test?

946

FullIssueSummary Feb2013

947

The Riddle of Protein Diagnostics: Future Bleak or Bright?

948

Conquering Cancer in Our Lifetime: New Diagnostic and Therapuetic Trends

949

Plasma-derived Tumor DNA analysis at whole genome resolution;

950

Validating Serum Markers for Monitoring of Cancer

951

Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing

952

Design of Tumor Biomarker-Monitoring Trials: A Proposal by the European Group on Tumor Markers

953

FullIssueSummary Jan2013

954

Associations of Alternative Markers of Glycemia with Hemoglobin A1c and Fasting Glucose

955

Quantitative PCR Analysis of DNA, RNAs, and Proteins in the Same Single Cell

956

The Evolving Threat of Influenza Viruses of Animal Origin and the Challenges in Developing Appropriate Diagnostics;

957

Performance Criteria for Testosterone Measurements Based on Biological Variation in Adult Males: Recommendations from the Partnership for the Accurate Testing of Hormones

958

Medicine Unplugged: The Future of Laboratory Medicine

959

Medicine Unplugged: The Future of Laboratory Medicine

960

Longitudinal Studies of Cardiac Troponin I in a Large Cohort of Healthy Children

961

FullIssueSummary Dec2012

962

Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population

963

On-Site Test for Cannabinoids in Oral Fluid

964

ClinChem FullIssueSummary Nov2012

965

Ectopic Pregnancy

966

Exome and Whole-Genome Sequencing as Clinical Tests: A Transformative Practice in Molecular Diagnostics

967

More Reliable On-Site Detection of Cannabis in Oral Fluid

968

Room for Improvement in National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines

969

Applicability of the AGREE II Instrument in Evaluating the Development Process and Quality of Current National Academy of Clinical Biochemistry Guidelines

970

The Human Salivary RNA Transcriptome Revealed by Massively Parallel Sequencing

971

Noninvasive Prenatal Diagnosis of Monogenic Diseases by Targeted Massively Parallel Sequencing of Maternal Plasma: Application to β-Thalassemia

972

Whole-Blood Thrombin Generation Monitored with a Calibrated Automated Thrombogram-Based Assay

973

Caution Is Needed in the Interpretation of Added Value of Biomarkers Analyzed in Matched Case Control Studies

974

Interpreting Cardiac Troponin Results from High-Sensitivity Assays in Chronic Kidney Disease without Acute Coronary Syndrome

975

Thyroid Function during Pregnancy: Who and How Should We Screen?

976

Circulating Human Hepcidin-25 Concentrations Display a Diurnal Rhythm, Increase with Prolonged Fasting, and Are Reduced by Growth Hormone Administration

977

Antibiotic Resistance: How Serious Is the Problem, and What Can Be Done?

978

A Unique Approach to Business Strategy as a Means to Enable Change in Global Healthcare: A Case Study

979

Establishing Pediatric Reference Intervals: A Challenging Task

980

Newer Fecal Tests: Opportunities for Professionals in Laboratory Medicine

981

Diagnostic Accuracy of Point-of-Care Fecal Calprotectin and Immunochemical Occult Blood Tests for Diagnosis of Organic Bowel Disease in Primary Care: The Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) Study

982

The Obesity Epidemic

983

Altering the Landscape for Women in Clinical Chemistry: Perspectives from Multigenerational Leaders

984

Elementary, My Dear Doctor Watson

985

Clinician's Perspective: Allan Jaffe

986

Patents and Laboratory Medicine: What Is Required to Turn an Unpatenable Natural Phenomenon or Law of Nature into a Patenable Invention?

987

Closing the Gaps in Pediatric Laboratory Reference Intervals: A CALIPER Database of 40 Biochemical Markers in a Healthy and Multiethnic Population of Children

988

Inappropriate Requesting of Glycated Hemoglobin (Hb A1c) Is Widespread: Assessment of Prevalence, Impact of National Guidance, and Practice-to-Practice Variability

989

Genetic Susceptibility for Coronary Heart Disease and Type 2 Diabetes Complications

990

Catch Me If You Can: Isolating Circulating Tumor Cells from Flowing Blood

991

Refining Noninvasive Prenatal Diagnosis with Single-Molecule Next-Generation Sequencing

992

Understanding the Mechanisms That Link Alcohol and Lower Risk of Coronary Heart Disease

993

Microtube Device for Selectin-Mediated Capture of Viable Circulating Tumor Cells from Blood

994

Fluorescence Sensor for the Quantification of Unbound Bilirubin Concentrations

995

Point/Counterpoint: Standardization of Cardiac Troponin I

996

Discerning Trends in Multiplex Immunoassay Technology with Potential for Resource-Limited Settings

997

Interview with Fred S. Apple on the Role of Sensitive Cardiac Troponin I Assay for Early Diagnosis of Myocardial Infarction

998

Interview with Samia Mora and Børge G. Nordestgaard on Comparison of LDL

999

Interview with Karl V. Voelkerding on Next-Generation Sequencing

1000

Interview with Graham H. Beastall on the Reinvention of Vitamin D and Its Implications for Clinical Chemistry